Skip to main content

Table 3 Comparisons of HDL-cholesterol levels in the three antipsychotic groups with stratification by BMI for outpatients

From: High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

  Olanzapine Risperidone Aripiprazole p-value
HDL-cholesterol BMI < 18.5 mg/dL 72.1 ± 18.7 (8) 81.3 ± 30.4 (4) 62.5 ± 3.4 (4) 0.959
18.5 ≤ BMI < 25 mg/dL 57.6 ± 13.4 (69) 61.4 ± 23.0 (96) 60.7 ± 17.7 (45) 0.442
BMI ≥ 25 mg/dL 53.0 ± 15.6 (61) 52.7 ± 15.8 (94) 51.9 ± 18.4 (52) 0.819
  1. Data are shown as the mean ± SD (number of subjects)
  2. Analyses of covariance among the three antipsychotics were performed for HDL-cholesterol with age, diastolic blood pressure, chlorpromazine-equivalent dosage and waist circumference as confounding variables
  3. Post-hoc analyses were performed by the Bonferroni method
  4. HDL high-density lipoprotein, BMI body mass index